Growth Opportunities in Single Cell Genomics and Proteomics in the United States

Growth Opportunities in Single Cell Genomics and Proteomics in the United States

Public Funding and Large Biopharma Investments Support Technological Advancements and Improved Analysis

RELEASE DATE
08-Dec-2023
REGION
North America
Deliverable Type
Market Research
Research Code: K998-01-00-00-00
SKU: HC_2023_402
AvailableYesPDF Download
$4,950.00
In stock
SKU
HC_2023_402
$4,950.00
DownloadLink
ENQUIRE NOW

Description

In recent years, single-cell analysis has changed rapidly. It began as a niche, specialized technology with few companies offering solutions, which then became commonly used in academia. Subsequently, its use has spread to areas such as biopharma, with more companies investing in the research and development (R&D) of single-cell analysis projects.

Globally, the single-cell genomics and proteomics market is growing at high rates. The United States represents about 60% of the total market and is on track to increase about 12% to 16% annually. Much of that growth is characterized by public funding, such as funding by the National Institutes of Health (NIH) and increasing biopharma investments. Greater adoption and better handling of artificial intelligence (AI) and machine learning (ML) tools will drive this market’s growth. These novel tools encourage the development of software and data analysis solutions to help researchers interpret data.

This report examines the US single-cell genomics and proteomics market and provides a forecast from 2023 to 2028. It assesses the market for single-cell analysis tools used for analytical and isolation purposes across workflows, technologies, and applications. Frost & Sullivan provides information on market concentration and evolution, leading providers, application areas, and technologies. This study will help vendors understand critical trends emerging for various application domains.

Table of Contents

Why is it Increasingly Difficult to Grow?

The Strategic Imperative 8™

The Impact of the Top 3 Strategic Imperatives on the US Single-cell Genomics and Proteomics Industry

Growth Opportunities Fuel the Growth Pipeline Engine™

Scope of Analysis

Segmentation

Key Competitors by Workflow

Growth Metrics

Growth Drivers

Growth Drivers (continued)

Growth Restraints

Forecast Assumptions

Revenue Forecast

Revenue Forecast Analysis

Revenue Forecast Analysis (continued)

Revenue Forecast by Workflow

Percent Revenue Forecast by Workflow

Forecast Analysis by Workflow

Revenue Forecast by Application

Percent Revenue Forecast by Application

Forecast Analysis by Application

Revenue Forecast by Technology

Percent Revenue Forecast by Technology

Forecast Analysis by Technology

Forecast Analysis by Technology (continued)

Pricing Trends and Forecast Analysis

Competitive Environment

Revenue Share

Revenue Share Analysis

Revenue Share Analysis (continued)

Key Companies to Watch

Key Companies to Watch (continued)

Company Solutions

Key Technologies and Workflow—Competitor Landscape

Interest in Single-cell Genomics

Single-cell Analysis Workflow Technology

Single-cell Analysis Workflow Technology (continued)

Single-cell Analysis Workflow Technology (continued)

Key Partnerships and Collaborations

Early-stage Company Funding Trends for Single-cell Analysis

Early-stage Company Funding Trends for Single-cell Analysis (continued)

Research Center Funding Trends for Single-cell Analysis

Single-cell Genomics and Proteomics Cores around the World

Growth Opportunity 1: Bioinformatics Tools and Platforms for Analyzing and Interpreting Large-scale Single-cell Data

Growth Opportunity 1: Bioinformatics Tools and Platforms for Analyzing and Interpreting Large-scale Single-cell Data (continued)

Growth Opportunity 2: Automation and High-throughput Solutions for Tissue Dissociation Processes

Growth Opportunity 2: Automation and High-throughput Solutions for Tissue Dissociation Processes (continued)

Growth Opportunity 3: The Integration of Multi-Omics Data to Drive the Development of Personalized Medicine

Growth Opportunity 3: The Integration of Multi-Omics Data to Drive the Development of Personalized Medicine (continued)

Your Next Steps

Why Frost, Why Now?

List of Exhibits

Legal Disclaimer

In recent years, single-cell analysis has changed rapidly. It began as a niche, specialized technology with few companies offering solutions, which then became commonly used in academia. Subsequently, its use has spread to areas such as biopharma, with more companies investing in the research and development (R&D) of single-cell analysis projects. Globally, the single-cell genomics and proteomics market is growing at high rates. The United States represents about 60% of the total market and is on track to increase about 12% to 16% annually. Much of that growth is characterized by public funding, such as funding by the National Institutes of Health (NIH) and increasing biopharma investments. Greater adoption and better handling of artificial intelligence (AI) and machine learning (ML) tools will drive this market s growth. These novel tools encourage the development of software and data analysis solutions to help researchers interpret data. This report examines the US single-cell genomics and proteomics market and provides a forecast from 2023 to 2028. It assesses the market for single-cell analysis tools used for analytical and isolation purposes across workflows, technologies, and applications. Frost & Sullivan provides information on market concentration and evolution, leading providers, application areas, and technologies. This study will help vendors understand critical trends emerging for various application domains.
More Information
Deliverable Type Market Research
Author Lucila Martin
Industries Healthcare
No Index No
Is Prebook No
Keyword 1 Proteomics Industry Trends
Keyword 2 Single-Cell Genomics Market
Keyword 3 Single-Cell Proteomics
Podcast No
WIP Number K998-01-00-00-00